Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Thromboelastography With Platelet Mapping to Guide Thromboprophylaxis Following Lower Extremity Revascularization for Peripheral Artery Disease

NCT07597239 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07597239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07597239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Thromboelastography With Platelet Mapping to Guide Thromboprophylaxis Following Lower Extremity Revascularization for Peripheral Artery Disease
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 1, 2023
Completion date
October 31, 2026
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, peripheral arterial disease(pad), platelet inhibition, pru(platelet reactivity unit), stent thrombosis, thromboelastography (teg), thrombosis